AstraZeneca Healthcare Policy Research VP James Cai On Building A CRO Community In China: An Interview With PharmAsia News
This article was originally published in The Pink Sheet Daily
Executive Summary
Cai talks about the growing CRO landscape in China and how multinational companies can work with local CROs to improve the clinical trial infrastructure.